Cancer cell
SCIENCE & INNOVATION

Voices from the Lab:<br>Nizar El-Murr on Immuno-Oncology

Q2 2021 Results

Sanofi’s financial results are now available

scientist

Updates on our COVID-19 Vaccines

Sanofi and GSK announced on May 27 the start of a phase 3 clinical trial for their COVID-19 recombinant vaccine candidate 

Q4 Results

The Upshot Series

Everything you Need to Know about Vaccines

2020 integrated report

2020 Integrated Report

An immersive journey to discover Sanofi’s breakthrough science, people, strategy and contribution to society

Diversity at Sanofi

Join us!

You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives

  • Camera
    Press releases
    2021-09-19MMMM DD YYYY
    ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC